tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Income Statement

Compare
4 Followers

CStone Pharmaceuticals Income Statement

Last quarter (Q2 2025), CStone Pharmaceuticals's total revenue was ¥24.73M, a decrease of -90.54% from the same quarter last year. In Q2, CStone Pharmaceuticals's net income was ¥-135.09M. See CStone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 407.20M¥ 463.84M¥ 481.36M¥ 243.72M¥ 1.04B
Gross Profit
¥ 240.15M¥ 304.30M¥ 278.38M¥ 136.89M¥ 797.41M
Operating Expenses
¥ 331.85M¥ 909.86M¥ 1.19B¥ 1.97B¥ 1.89B
Depreciation and Amortization
¥ 18.93M¥ 58.19M¥ 44.54M¥ 22.66M¥ 14.80M
EBITDA
¥ -76.43M¥ -297.23M¥ -849.66M¥ -1.90B¥ -1.20B
Operating Income
¥ -91.69M¥ -605.57M¥ -912.15M¥ -1.83B¥ -1.09B
Other Income/Expenses
¥ 485.00K¥ 238.33M¥ 9.47M¥ -90.66M¥ -129.07M
Pretax Income
¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B¥ -1.22B
Net Income
¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B¥ -1.22B
Per Share Metrics
Basic EPS
¥ -0.07¥ -0.29¥ -0.77¥ -1.65¥ -1.17
Diluted EPS
¥ -0.07¥ -0.29¥ -0.77¥ -1.65¥ -1.17
Weighted Average Shares Outstanding
1.28B 1.26B 1.17B 1.16B 1.04B
Weighted Average Shares Outstanding (Diluted)
1.28B 1.26B 1.17B 1.17B 1.05B
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History